Loews logo

LoewsNYSE: L

Profile

Country:

United States

IPO:

17 March 1980

Next earnings report:

05 February 2025

Last dividends:

21 August 2024

Next dividends:

27 November 2024
$18.30 B
0%vs. 3y high
89%vs. sector
-39%vs. 3y high
25%vs. sector
-4%vs. 3y high
37%vs. sector
-12%vs. 3y high
16%vs. sector

Price

after hours | Wed, 20 Nov 2024 22:59:41 GMT
$84.49-$0.14(-0.17%)
$4.40 B$401.00 M

Analysts recommendations

Institutional Ownership

L Latest News

LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK
prnewswire.com12 November 2024 Sentiment: POSITIVE

On November 12, 2024, Loews Corporation (NYSE: L) announced that it will pay a quarterly dividend of $0.0625 per share of Common Stock on December 10, 2024, to shareholders who are on record as of November 27, 2024. Loews Corporation operates in various sectors, including insurance, energy, hospitality, and packaging.

Loews Corporation to Release Third Quarter 2024 Results on November 4, 2024
prnewswire.com15 October 2024 Sentiment: POSITIVE

NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Loews Corporation (NYSE: L) is set to announce its financial results for the third quarter of 2024 on Monday, November 4, 2024. The company will also share comments about its earnings on its website that day.

FDA approves Roche's Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy
globenewswire.com13 September 2024 Sentiment: POSITIVE

On September 13, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq HybrezaTM, which is the first PD-(L)1 inhibitor that can be injected under the skin. This new method allows for a subcutaneous injection that takes about seven minutes, compared to the 30-60 minutes needed for the traditional intravenous infusion. Tecentriq Hybreza will be available for all the same uses as the intravenous version for adult patients in the U.S., including various cancers like lung, liver, skin, and soft tissue cancers.

FDA Approves Genentech's Tecentriq Hybreza, the First and Only Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
businesswire.com12 September 2024 Sentiment: POSITIVE

Genentech, part of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq Hybreza™ (atezolizumab and hyaluronidase-tqjs). This is the first PD-(L)1 inhibitor that can be given as a subcutaneous injection in the U.S. The injection takes about seven minutes, which is much quicker than the usual 30-60 minutes for intravenous administration.

Loews Corporation Announces Favorable Resolution of Boardwalk Pipelines Acquisition Litigation
prnewswire.com09 September 2024 Sentiment: POSITIVE

On September 9, 2024, Loews Corporation (NYSE: L) announced that the Delaware Court of Chancery determined there was no wrongdoing related to its 2018 purchase of minority limited partner interests in its Boardwalk Pipelines subsidiary.

LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK
prnewswire.com06 August 2024 Sentiment: POSITIVE

On August 6, 2024, Loews Corporation (NYSE: L) announced that it will pay a quarterly dividend of $0.0625 per share of Common Stock on September 3, 2024. This payment will go to shareholders who are on record as of the end of business on August 21, 2024. Loews Corporation operates in various sectors, including insurance, energy, hospitality, and packaging.

Loews Corporation Announces CEO Transition:
prnewswire.com29 July 2024 Sentiment: POSITIVE

James Tisch will step down as President and CEO of Loews Corporation on December 31, 2024, and will be replaced by Benjamin Tisch, who is currently the Senior Vice President of Corporate Development and Strategy. Following this change, James Tisch will take on the role of Chairman of the Board of Directors. Additionally, Benjamin Tisch and Alexander Tisch, the CEO of Loews Hotels & Co, will also join the Board.

Loblaw, George Weston to pay $500M to settle bread price-fixing lawsuit
proactiveinvestors.com25 July 2024 Sentiment: NEGATIVE

Loblaw (TSX:L) and its parent company George Weston have agreed to pay $500 million to settle a class action lawsuit regarding the grocery chain's involvement in bread price-fixing. The plaintiffs alleged that between 2001 and 2015, a group of companies including Loblaws and the Weston companies, Metro, Walmart Canada, Giant Tiger and Sobeys and its owner Empire Company Limited engaged in a price-fixing conspiracy which artificially raised the prices of packaged bread.

Loews Corporation to Release Second Quarter 2024 Results on July 29, 2024
prnewswire.com09 July 2024 Sentiment: POSITIVE

NEW YORK, July 9, 2024 /PRNewswire/ -- Loews Corporation (NYSE: L) will report second quarter 2024 financial results on Monday, July 29, 2024. On that date the Company will also post earnings remarks on its website.

Loews Hotels' Tisch: Pent-up demand for lodging has waned while other areas are getting stronger
youtube.com03 June 2024 Sentiment: POSITIVE

Jonathan Tisch, Loews Hotels executive chairman and New York Giants co-owner, joins 'Squawk on the Street' to discuss the executive chairman's thoughts on consumer spending, the company's hotel in Texas, and the trend for corporate travel.

What type of business is Loews?

Loews Corporation is a large diversified holding company, whose subsidiaries are engaged in various activities: insurance, drilling services, natural gas transportation and storage, hotel business, and packaging production. Loews was registered in 1969 and is headquartered in New York. Loews' subsidiaries include: - CNA Financial Corp. - an insurance holding company. - Diamond Offshore Drilling, Inc. - provides contract drilling services to the energy industry worldwide. - Boardwalk Pipeline Partners, LP - involved in natural gas and liquefied gas transportation and storage. - Loews Hotels Holding Corporation - manages a network of hotels. - Altium Packaging LLC - a manufacturer and supplier of packaging solutions in North America.

What sector is Loews in?

Loews is in the Financial Services sector

What industry is Loews in?

Loews is in the Insurance - Property & Casualty industry

What country is Loews from?

Loews is headquartered in United States

When did Loews go public?

Loews initial public offering (IPO) was on 17 March 1980

What is Loews website?

https://www.loews.com

Is Loews in the S&P 500?

Yes, Loews is included in the S&P 500 index

Is Loews in the NASDAQ 100?

No, Loews is not included in the NASDAQ 100 index

Is Loews in the Dow Jones?

No, Loews is not included in the Dow Jones index

When was Loews the previous earnings report?

No data

When does Loews earnings report?

The next expected earnings date for Loews is 05 February 2025